Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Neoplasms

Explore clinical trials studying Central Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

533 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Neoplasms trial results

Active, Not Recruiting

A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

NCT03899792

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Breast Diseases, +52 more
Locations
  • Childrens Hospital of Los Angeles Los Angeles, California, United States
  • The Children's Hospital for Cancer and Blood Disorders Aurora, Colorado, United States
  • Nemours Children's Health Orlando, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

NCT02932280

Conditions
Central Nervous System Neoplasms, Central Nervous System Tumor, Disease, +18 more
Locations
  • Phoenix Children'S Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Stanford University School of Medicine and Stanford Cancer Institute Palo Alto, California, United States
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
View Trial Details
Active, Not Recruiting

Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

NCT03834961

Conditions
Central Nervous System Neoplasm, Central Nervous System Neoplasms, Infantile Fibrosarcoma, +7 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 80 locations
View Trial Details
Active, Not Recruiting

LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)

NCT04446962

Conditions
Central Nervous System Neoplasms, Central Nervous System Neoplasms, Primary, Hemic and Lymphatic Diseases, +16 more
Locations
  • CHU Amiens Amiens, France
  • CHU Angers Angers, France
  • CH côte Basque Bayonne, France
  • CHU Besançon Besançon, France
View all 28 locations
View Trial Details
Active, Not Recruiting

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

NCT00978458

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Arizona Oncology Services Foundation Phoenix, Arizona, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States
View all 168 locations
View Trial Details
Active, Not Recruiting

A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma

NCT05664243

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Louisville Hospital/James Graham Brown Cancer Center Louisville, Kentucky, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details

Related conditions